Changes in Proton Pump Inhibitor Prescribing Trend over the Past Decade and Pharmacists' Effect on Prescribing Practice at a Tertiary Hospital

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2018 Jul 13

PMID 29996830

Citations 32

Authors

Hongli Luo

Qingze Fan

Shunlin Xiao

Kun Chen

Affiliations

Soon will be listed here.

Abstract

Background: Proton pump inhibitors (PPIs) remain one of the world's most frequently prescribed medications and there is a growing number of publications on correct versus incorrect use of PPIs worldwide. The objective of this observational retrospective study was to assess changes in PPI prescribing trends over the past decade and pharmacists' effect on optimizing PPI prescribing practice at a tertiary hospital in China.

Methods: We collected the prescriptions of PPIs in our hospital from January 2007 to December 2016. Then the rate of PPI prescribing, the defined daily doses (DDDs) and expenditures were calculated and plotted to show the change in utilization of and expenditure on PPIs. Reasons behind this change and effect of pharmacists' intervention were evaluated by investigating the rationality of PPI use through sample surveys of patients of pre-intervention (Jul.-Dec. 2015) and post-intervention (Jul.-Dec. 2016).

Results: In outpatient settings, the rate of PPI prescribing remained almost constant, utilization (from 135,808 DDDs to 722,943 DDDs) and expenditure (from 1.85 million CNY to 7.96 million CNY) increased for the past ten years, dominated by oral formulations and rabeprazole. In contrast, in inpatient settings, the rate of PPI prescribing (from 20.41 to 37.21%), utilization (from 132,329 DDDs to 827,747 DDDs) and expenditure (from 3.15 million CNY to 25.29 million CNY) increased from 2007 to 2015 and then decreased, dominated by injection formulations and omeprazole. Pharmacist interventions could significantly promote the rational use of PPIs (44.00% versus 26.67%), decrease PPI use and reduce patients' charges (P < 0.05).

Conclusions: The utilization of and expenditure on PPIs grew due to the increase of patients and irrational use of PPI. Pharmacist interventions help to reduce PPI utilization and expenditure and enhance rationality for inpatients, but much work should be done to regulate injection and originator formulas, and improve the rationality in the future.

Citing Articles

Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit.

Zhang P, Wang S, Zhi T, Ye N, Sun H, Qin X Front Pharmacol. 2025; 15():1401335.

PMID: 39840110 PMC: 11746069. DOI: 10.3389/fphar.2024.1401335.

Medication Exposure and Risk of Dementia and Alzheimer's Disease.

Sharma N, An S, Kim S Int J Mol Sci. 2024; 25(23).

PMID: 39684561 PMC: 11641710. DOI: 10.3390/ijms252312850.

Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database.

Baptista A, Marreiros A, Macedo A, Coelho A Cureus. 2024; 16(7):e63636.

PMID: 39092339 PMC: 11292151. DOI: 10.7759/cureus.63636.

Clinical Characteristics of Patients With Previous Helicobacter pylori Infection-Induced Atrophic Gastritis.

Kishikawa H, Nakamura K, Takarabe S, Katayama T, Sasaki A, Miura S Cureus. 2024; 16(6):e63368.

PMID: 39070512 PMC: 11283760. DOI: 10.7759/cureus.63368.

Estimation of CDK inhibitors by RP-HPLC: application for pharmacokinetic interactions studies with PPIs.

Desai M, Patil P, Shenoy G, Channabasavaiah J Bioanalysis. 2024; 16(15):801-812.

PMID: 39016209 PMC: 11415017. DOI: 10.1080/17576180.2024.2372162.

References

Ho S, Hsieh M, Yang S, Yeh Y, Wang Y, Yeh C . Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study. Medicine (Baltimore). 2015; 94(29):e1227. PMC: 4603020. DOI: 10.1097/MD.0000000000001227. View

Abraham N . Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol. 2012; 28(6):615-20. DOI: 10.1097/MOG.0b013e328358d5b9. View

Bez C, Perrottet N, Zingg T, Leung Ki E, Demartines N, Pannatier A . Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. J Eval Clin Pract. 2012; 19(2):374-8. DOI: 10.1111/j.1365-2753.2012.01838.x. View

Grant K, Al-Adhami N, Tordoff J, Livesey J, Barbezat G, Reith D . Continuation of proton pump inhibitors from hospital to community. Pharm World Sci. 2006; 28(4):189-93. DOI: 10.1007/s11096-006-9028-4. View

Rotman S, Bishop T . Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009. PLoS One. 2013; 8(2):e56060. PMC: 3572154. DOI: 10.1371/journal.pone.0056060. View

Chandra S, Agarwal D, Surana A . Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation. Am J Gastroenterol. 2013; 108(2):277-8. DOI: 10.1038/ajg.2012.394. View

Hulot J, Collet J, Silvain J, Pena A, Bellemain-Appaix A, Barthelemy O . Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. J Am Coll Cardiol. 2010; 56(2):134-43. DOI: 10.1016/j.jacc.2009.12.071. View

Hwang K, Kolarov S, Cheng L, Griffith R . Stress ulcer prophylaxis for non-critically ill patients on a teaching service. J Eval Clin Pract. 2007; 13(5):716-21. DOI: 10.1111/j.1365-2753.2006.00742.x. View

Frelinger 3rd A, Lee R, Mulford D, Wu J, Nudurupati S, Nigam A . A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. J Am Coll Cardiol. 2012; 59(14):1304-11. DOI: 10.1016/j.jacc.2011.12.024. View

10.

Tang Y, Zhang X, Yang C, Yang L, Wang H, Zhang X . Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China. BMC Health Serv Res. 2013; 13:183. PMC: 3662578. DOI: 10.1186/1472-6963-13-183. View

11.

Armstrong D . Intravenous proton pump inhibitor therapy: a rationale for use. Rev Gastroenterol Disord. 2005; 5 Suppl 2:S18-30. View

12.

Ahn J, Eom C, Jeon C, Park S . Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013; 19(16):2560-8. PMC: 3646149. DOI: 10.3748/wjg.v19.i16.2560. View

13.

Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L . Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003; 17(12):1503-6. DOI: 10.1046/j.1365-2036.2003.01600.x. View

14.

Kazberuk M, Brzosko S, Hryszko T, Naumnik B . Overuse of proton pump inhibitors and its consequences. Postepy Hig Med Dosw (Online). 2016; 70(0):1112-1116. DOI: 10.5604/17322693.1222106. View

15.

Ramirez E, Lei S, Borobia A, Pinana E, Fudio S, Munoz R . Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol. 2010; 5(4):288-97. DOI: 10.2174/157488410793352067. View

16.

Luo H, Fan Q, Xiao S, Chen K . Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations. PLoS One. 2017; 12(10):e0186302. PMC: 5646810. DOI: 10.1371/journal.pone.0186302. View

17.

. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 2000; 56(4):347-79. DOI: 10.1093/ajhp/56.4.347. View

18.

Forgacs I, Loganayagam A . Overprescribing proton pump inhibitors. BMJ. 2008; 336(7634):2-3. PMC: 2174763. DOI: 10.1136/bmj.39406.449456.BE. View

19.

Nardino R, Vender R, Herbert P . Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000; 95(11):3118-22. DOI: 10.1111/j.1572-0241.2000.03259.x. View

20.

Guda N, Noonan M, Kreiner M, Partington S, Vakil N . Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?. Am J Gastroenterol. 2004; 99(7):1233-7. DOI: 10.1111/j.1572-0241.2004.30894.x. View